CARIELLE KEMP: Open Payments
NPI 1932650413 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $329 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 2 | $55 |
| Genentech USA, Inc. | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| pharmaand GmbH | 3 | $19 |
| TOLMAR, INC. | 1 | $17 |
Products named: Zoladex, Rubraca, Tecentriq, RYBREVANT, LYNOZYFIC, PADCEV, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
